The independent source for health policy research, polling, and news.
1,661 - 1,680 of 15,457 Results
With artificial intelligence in health care on the rise, eye screenings for diabetic retinopathy are emerging as one of the first proven use cases of AI-based diagnostics in a clinical setting.
The FDA and some oncologists have resisted efforts to require a quick, cheap gene test that could prevent thousands of deaths from a bad reaction to a common cancer drug.
The end goal for a conservative Christian group’s mifepristone case before the Supreme Court: a de facto nationwide abortion ban.
Ballad Health was granted the nation’s largest state-sanctioned hospital monopoly in 2018. Since then, its emergency rooms have become more than three times as slow.
For years, addiction response teams have traveled around Florida to connect people who have overdosed with resources and recovery centers. Now, a handful have a new tool in their kit: buprenorphine, which can help prevent the cravings and withdrawal symptoms that lead to more drug use.
There are legal safeguards to protect patients from big bills like out-of-network air-ambulance rides. But insurers may not pay if they decide the ride wasn’t medically necessary.
KFF Health News and California Healthline staff made the rounds on national and local media in recent weeks to discuss their stories. Here’s a collection of their appearances.
A state policy to extend Medi-Cal to qualified Californians without legal residency is running up against a federal requirement to resume eligibility checks. The redetermination process is causing many Latinos, who make up a majority of Medi-Cal beneficiaries, to be disenrolled.
A years-long process that would have created heat standards for California workers in warehouses, steamy kitchens, and other indoor job sites catapulted into chaos Thursday when Gov. Gavin Newsom’s administration pulled its support. Regulators, saying they felt “blindsided,” approved the regulation anyway. It’s unclear what happens next.
Saturday marks the 14th anniversary of the still somewhat embattled Affordable Care Act. Health and Human Services Secretary Xavier Becerra joins host Julie Rovner to discuss the accomplishments of the health law — and the challenges it still faces. Also this week, Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Mary Agnes Carey of KFF Health News join Rovner to discuss what should be the final funding bill for HHS for fiscal 2024, next week’s Supreme Court oral arguments in a case challenging abortion medication, and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
Commissioner Martin O’Malley testifies to two Senate panels that his agency will stop the “injustices” of suspending people’s monthly benefits to recover alleged overpayments. The burden will be on the Social Security Administration to prove the beneficiary was to blame.
With U.S. syphilis rates climbing to the worst level in seven decades, public health experts and the federal Indian Health Service are scrambling to detect and treat the disease in Native American communities, where babies are infected at a higher rate than in any other demographic.
Most healthy men produce sufficient testosterone as they age. Yet online ads and telehealth sites are promoting testosterone drugs with flawed promises of boosting libido and busting stomach fat.
Savings estimated by the Congressional Budget Office from allowing the federal government to negotiate Medicare drug prices are based on a 10-year cumulative projection.
The pain and trauma from repeated needle sticks leads some kids to hold on to needle phobia into adulthood. Research shows the biggest source of pain for children in the health care system is needles. But one doctor thinks he has a solution and is putting it into practice at two children’s hospitals in Northern California.
Some Americans mistakenly believe medication to prevent HIV transmission through sex is just for certain groups such as gay men, but anyone who’s at risk for contracting HIV through sex could benefit.
Republican Gov. Brian Kemp’s Georgia Pathways to Coverage program has seen anemic enrollment while chalking up millions in start-up costs — largely in technology and consulting fees. Critics say the money’s being wasted on a costly and ineffective alternative to Obamacare’s Medicaid expansion.
© 2026 KFF